Skip to main content
Assets
Atlas Copco logo
ATCO-A.STO
Atlas Copco
Industrials · Industrial Machinery & Supplies & Components

Industrial technology group supplying compressors, vacuum equipment, power tools, and assembly systems to global manufacturers.

HQ: SwedenListed: Sweden

Historical AI Consensus

Audit every published iPulse AI forecast batch and immutable historical research document for Atlas Copco.

Historical AI Consensus

This page preserves the research and market snapshot packaged for this batch. It is not updated with later prices or revised advisor outputs.

Symbol
ATCO-A.STO
Batch
7
Published
September 20, 2026
AI Advisors
14

Historical AI Consensus Investment Thesis

Atlas Copco (ATCO-A) Stock Forecast and AI Rating

Deep analysis published Original pricing snapshot 12 min read
Published 1-Year and 5-Year Forecast Outlook

Forecast targets and rating

Published batch rating

NEUTRAL

Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.

2027

1-Year

PARTIAL SELL

kr195

-1.2%0.0% incl. dividends
2031

5-Year

NEUTRAL

kr245

+24.1%+31.7% incl. dividends

Published batch insight

Industrial Vacuum Infrastructure Dominance Faces Valuation Friction Under Tightening Global Rates

Input reports show high consensus that structural semiconductor vacuum demand and non-discretionary aftermarket service annuities drive durable earnings compounding. However, this fundamental operational strength confronts persistent valuation friction from elevated global discount rates, ensuring that multiple compression moderates equity price appreciation despite formidable balance-sheet resilience.

Deep Forecast Analysis by iPulse AI Engine

This analysis preserves the original published batch. Audit published forecasts in full transparency

Machiavelli (Insider) advisor portraitWarren Buffett (Value Purist) advisor portraitUniversal Investor (Polymath) advisor portraitSherlock Holmes (Whistleblower) advisor portraitMichael Burry (Vulture) advisor portraitSuperintelligence (Anthropologist) advisor portraitRay Dalio (Strategist) advisor portraitJ.P. Morgan (Titan) advisor portraitElon Musk (Visionary) advisor portrait

Machiavelli (Insider), Warren Buffett (Value Purist), Universal Investor (Polymath), Sherlock Holmes (Whistleblower), Michael Burry (Vulture), Superintelligence (Anthropologist), Ray Dalio (Strategist), J.P. Morgan (Titan), Elon Musk (Visionary). Some archetypes run in multiple modes, resulting in 14 advisors total.

Computed on these frontier AI models
Gemini AI model logoGeminiClaude AI model logoClaudeChatGPT AI model logoChatGPT

Full published thesis

Executive Summary

If you invested $10,000 in Atlas Copco at the forecast anchor (2026-09-18): $14,469 in five years versus $13,892 for S&P 500 benchmark.

Five-year synthesized consensus forecast for Atlas CopcoThe diagram shows the synthesized consensus value path for Atlas Copco, forecast milestones, and a comparison with S&P 500 benchmark. including estimated net dividends of 1.2% per year.$10,000$12,500$15,000$14,469 (+44.7%)$13,892 (+38.9%)Anchor2026-09-182027(1Y)2028(2Y)2029(3Y)2030(4Y)2031(5Y)
Atlas Copco · Synthesized ConsensusS&P 500 benchmark

* Return is calculated incl. 1.2% net dividend yield for Atlas Copco.

Figure: Five-year synthesized consensus value path for Atlas Copco compared with S&P 500 benchmark. The path uses the synthesizer’s normalized opinion weights.
20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each step

Frozen forecast from 18 Sept 2026. Prices in SEK; returns exclude dividends. Each quarter is compounded from the previous quarter.

Anchor: 197.2 SEK1-year price return: -1.23%5-year price return: +24.08%

Swipe the table horizontally to read every column.

Twenty quarterly synthesized price forecasts in SEK, with returns and rationale
QuarterTarget (SEK)Quarter returnTotal returnForecast rationale
Q4 2026193.91-1.67%-1.67%Elevated central bank policy rates and five percent sovereign yields trigger initial valuation multiple compression. Solid semiconductor vacuum shipments cushion the equity, but high opportunity costs for long-duration quality compounders cap immediate share price performance.
Q1 2027193.56-0.18%-1.85%Full-year 2026 reporting confirms operating margin resilience above twenty percent alongside robust free cash flow. Resilient aftermarket service billings offset sluggish general manufacturing activity, stabilizing investor sentiment despite restrictive monetary policy and cautious customer budgets.
Q2 2027194.54+0.51%-1.35%Annual dividend capital distribution temporarily dampens quoted share prices. Simultaneously, high European energy costs and elevated financing rates delay discretionary factory retooling, causing moderate valuation multiple de-rating that offsets early semiconductor vacuum order conversion.
Q3 2027194.78+0.12%-1.23%General industrial capex softness across European machinery clients offsets steady advanced-node vacuum deliveries. Stable operating cash flow and high customer switching costs prevent margin degradation, keeping quarterly equity valuation essentially unchanged in disciplined consolidation.
Q4 2027197.35+1.32%+0.08%Initial equipment deliveries for next-generation sovereign fab construction lines in North America and Japan accelerate. Strong fourth-quarter Vacuum Technique bookings provide operational relief, driving modest upward price momentum heading into the fiscal year-end close.
Q1 2028201.79+2.25%+2.33%Central bank monetary pauses ease corporate financing strains, encouraging industrial customers to resume deferred machinery upgrades. Expanding demand for energy-efficient Variable Speed Drive compressors accelerates organic revenue growth, prompting positive quarterly earnings revisions and price appreciation.
Q2 2028203.44+0.82%+3.17%Seasonal dividend detachment moderately trims quoted equity values. Underlying operations maintain strong twenty-one percent operating margins, but automotive assembly tool deferrals in Western Europe counterbalance high-margin vacuum pump shipments, resulting in modest price progress.
Q3 2028206.15+1.33%+4.54%Accretive bolt-on acquisitions in specialty gas compression and industrial automation expand consolidated revenues. Distribution synergies enhance operating leverage, lifting quarterly net earnings and attracting long-term institutional capital seeking resilient, cash-generative industrial technology exposure.
Q4 2028210.27+2.00%+6.63%Commercial tooling for advanced packaging and sub-two-nanometer lithography drives double-digit Vacuum Technique shipments. High-margin chemical abatement installations expand segment profitability, propelling the equity past prior cyclical consolidation ranges on validated fundamental cash delivery.
Q1 2029214.35+1.94%+8.70%Annual disclosures highlight return on capital employed maintaining twenty-four percent, supported by aftermarket service expansion past thirty-eight percent of revenue. Strong owner earnings and pristine solvency reassure markets of cash flow durability, driving steady valuation gains.
Q2 2029216.11+0.82%+9.59%Dividend distribution coincides with a modeled mid-cycle digestion lull in general manufacturing tools. Slower order intake briefly moderates quarterly revenue expansion, resulting in a mild equity pullback while recurring service cash flows preserve baseline profitability.
Q3 2029217.34+0.57%+10.21%Industrial decarbonization retrofits across North America re-energize Compressor Technique bookings. High factory utilization rates stimulate consumable spare-part sales, enabling the group to defend operating margins above twenty-one percent and driving constructive share price recovery.
Q4 2029221.95+2.12%+12.55%High-volume commercial adoption of high-numerical-aperture lithography systems generates record vacuum solution billings. Rapid fixed-cost absorption expands operating profit, prompting sell-side earnings upgrades and driving confident institutional accumulation into the annual financial close.
Q1 2030225.63+1.66%+14.42%Annual reporting confirms record operating cash generation approaching thirty-five billion kronor. Expansion in connected assembly tools for automated transport manufacturing bolsters returns on invested capital, supporting solid first-quarter price appreciation on clean cash conversion.
Q2 2030228.68+1.35%+15.96%Scheduled annual dividend payments neutralize operational gains during the second quarter. Steady industrial activity across Asian and European manufacturing hubs preserves trading ranges without significant directional repricing, balancing capital distribution against mature economic expansion.
Q3 2030231.79+1.36%+17.54%Specialized high-pressure gas compression orders accelerate, driven by commercial carbon capture and clean hydrogen infrastructure investments. Expanded addressable market exposure broadens top-line compounding, insulating operating performance from localized regional manufacturing lulls.
Q4 2030235.50+1.60%+19.42%Disciplined delivery execution across all four business areas ensures full-year revenue targets are achieved. Exceptional working-capital control and high free cash flow conversion enhance balance sheet flexibility, generating positive investor sentiment into year-end trading.
Q1 2031239.10+1.53%+21.25%Annual financial disclosures confirm a decade of unbroken economic value creation. Fundamental compounding in net income comfortably absorbs lingering multiple contraction toward historical medians, sustaining constructive upward equity price progress on verified cash generation.
Q2 2031241.97+1.20%+22.70%Seasonal post-dividend price reset balances continued expansion in high-margin semiconductor vacuum servicing. Market trading remains tight and disciplined as investors absorb predictable capital distributions against a mature, steady-state macroeconomic industrial backdrop.
Q3 2031244.68+1.12%+24.08%Terminal forecast horizon crystallizes the group's role as an indispensable thermodynamic infrastructure provider. A normalized twenty-five times earnings multiple on expanded earnings power delivers steady long-term capital appreciation, concluding a resilient five-year compounding cycle.

The fundamental economic thesis centers on a durable compounding engine operating at the intersection of sub-nanometer semiconductor fab expansion and industrial energy efficiency retrofits. Indispensable dry vacuum platforms and proprietary variable-speed compressors anchor pricing power, while an installed base generating over thirty-five percent recurring aftermarket revenue insulates operating margins above twenty percent. However, starting valuation near thirty-five times earnings creates severe duration sensitivity under higher global risk-free rates. While earnings compound at high single digits, the strongest counterargument emphasizes that inevitable multiple contraction toward historical norms will absorb fundamental progress, leaving equity appreciation constrained relative to corporate execution.

Key insights

  • Backlog conversion velocity dictates near-term cash quality, as working-capital absorption during semiconductor ramp-ups can depress operating cash flows despite headline order surge strength.
  • High customer switching costs and telemetry-linked maintenance contracts turn installed machinery into non-discretionary cash annuities, establishing a structural floor under gross margins across industrial cycles.
  • Disciplined programmatic acquisitions funded entirely from organic free cash flow systematically consolidate fragmented flow-control niches, driving persistent return on capital employed above twenty-four percent.

Deep Dive

The prevailing market belief treats the business as an untouchable quality compounder with tech-like immunity from macro cycles. Sell-side consensus anchors heavily on recent record second-quarter semiconductor vacuum orders as proof of an open-ended artificial intelligence supercycle. Investors willingly pay thirty-five times earnings, assuming structural moat insulation, non-discretionary service contracts, and impeccable execution permanently shield cash flows from elevated interest rates and industrial demand fatigue.